Metabolic Research

Cagrilintide

Long-acting amylin analogue

Also known as NN9838, AM833.

A lipidated amylin analogue studied at amylin and calcitonin receptors, frequently paired with GLP-1 agonists in preclinical energy-balance research.

Current lot: SN-CAG-2608
Purity: 99.16% by HPLC
Tested: Aug 2, 2026
Stocked in: United States

Synamino Sciences research vial with a silver cap on a navy background

Ships from

Vial size

$69.00

USD · 5 mg · In stock

Qty

Order by 2:00 PM PT for same-day dispatch from Reno, Nevada. 1–3 business days by USPS Priority and UPS. Free shipping over $150.00.

For laboratory research use only. Not for human or veterinary use.

About the compound

Cagrilintide is an acylated analogue of amylin, the pancreatic hormone co-secreted with insulin. It is used to study amylin-receptor signalling and combination models with incretin agonists.

Supplied as a lyophilized powder.

Studied inAmylin receptors · Calcitonin receptors · Combination models

Certificate of analysis

The certificate for the lot currently shipping. Every vial in that lot carries the same lot number on its label.

Certificate of analysis

Cagrilintide · 5 mg

Lot SN-CAG-2608 · tested Aug 2, 2026

99.16%

Purity by HPLC

Labeled: 5 mg
Measured: 5.2 mg
Panel: 6 passed · 2 reported
Laboratory: Independent ISO/IEC 17025 accredited laboratory

Assay	Method	Result	Outcome
Appearance	Visual	White lyophilized powder	Pass
Purity	HPLC · spec ≥ 98%	99.16%	Pass
Net peptide content	HPLC	5.2 mg	Reported
Identity	LC-MS	Confirmed	Pass
Heavy metals	ICP-MS	Not detected	Pass
Sterility	USP <71>	No growth	Pass
Endotoxin	LAL · USP <85>	< 0.05 EU/mL	Reported
Residual solvents	GC-HS	Within limits	Pass

Specification and storage

CAS number: 1415456-99-3
Molecular formula: C194H312N54O59S2
Molecular weight: 4409.0 g/mol
Residues: 37
Sequence: (C19 diacid)-γGlu-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (Cys2–Cys7 disulfide)
Reference record: PubChem entry

Storage

Sealed lyophilized vials are stable at room temperature for short periods; store at 2–8 °C for routine use.
For long-term storage keep sealed vials at −20 °C, protected from light and moisture.
Reconstituted solutions should be refrigerated at 2–8 °C and used within the period defined by your laboratory's protocol.

Literature

Peer-reviewed publications on this compound. Provided for reference; they are not claims about this product.

01
Journal of Medicinal Chemistry · 2021
Development of Cagrilintide, a Long-Acting Amylin Analogue
Kruse T, Hansen JL, Dahl K, et al.
02
Lancet · 2021
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Lau DCW, Erichsen L, Francisco AM, et al.
03
Lancet · 2021
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
Enebo LB, Berthelsen KK, Kankam M, et al.

Studied alongside

Semaglutide
GLP-1 receptor agonist
from $49.00
Retatrutide
GIP / GLP-1 / glucagon triple agonist
from $79.00

Research notice

Cagrilintide is supplied for in vitro laboratory research and analytical use by qualified professionals. It is not a medicine, supplement or cosmetic, has not been evaluated by any regulator, and is not for human or veterinary use. Published findings cited on this page are provided for reference and are not claims about this product.